Diabetes mellitus is a disease with major long-term implications, not only for the health and well-being of affected individuals, but also for costs to the National Health Service.
Treatment of the disease and its complications takes up 4-5% of total health care expenditure in the U.K. These costs are dominated by in-patient care for the complications arising from diabetes.
This paper presents a review of studies which have been carried out on the costs of diabetes and its complications.
For such a chronic and potentially disabling disease with numerous complications it is surprising that costs have not been more extensively researched.
Mots-clés Pascal : Diabète, Coût, Traitement, Complication, Hospitalisation, Endocrinopathie, Economie santé, Analyse coût efficacité, Royaume Uni, Europe, Homme
Mots-clés Pascal anglais : Diabetes mellitus, Costs, Treatment, Complication, Hospitalization, Endocrinopathy, Health economy, Cost efficiency analysis, United Kingdom, Europe, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0149634
Code Inist : 002B21E02B. Création : 199406.